Expression of PARP-1 in Multiple Sclerosis Patients
Expression of PARP-1 in Optic Neuritis of Multiple Sclerosis Patients
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 4 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Blood sampling
What it measured
Main measures
measure PARP-1 mRNA
2 weeks
Immune response
Other measures (1)
Optic nerve, RNFL and GCC layer affection by MS
2 weeks
Retina scans (OCT)Immune response
Who could take part
MS (type not specified) · 20 to 45
Show the full criteria
Inclusion criteria
* Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria
Exclusion criteria
* • Isolated optic neuritis.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protocol will be approved by the Scientific Research Ethical Committee, Faculty of Medicine, Sohag University.
Loading reviews and guidelines…
History
Started
Aug 2021
Main results due
Mar 2022
Finished
Apr 2022